Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Joanna Poulton

Joanna Poulton

Sources of Funding

  • Wellcome Trust
  • MRC

Routine clinical referrals

DNA diagnostics are carried out in collaboration with the Molecular Genetics Laboratories at the Churchill Hospital and detailed characterisation of defects of specific complexes in infants and young children by Dr GK Brown

Please follow this link to the form that should accompany any samples for DNA analysis that you send: Download Form

From 1st April 2007 this is funded by Rare Mitochondrial Disease Service for Adults and Children (NCG)

scholarships and prizes 

2013     FRCP

1997     RCPCH

1996     Royal Society University Research Fellowship

1992     Ronnie MacKeith prize, British Paediatric Neurological Association

1991     Wellcome Senior Research Fellowship in Clinical Science

1991     DM Oxford

1990     Medical Research Council Travelling Fellowship

1989     Sanofi Essay Prize (Advances in genetics and application to epilepsy)           

1986     Action Research Training Fellowship

1982     MRCP (London)

1979     BM BCh Oxford

1977     Essay Prize in Pathology (Oxford Medical School)

1976     BA Oxford Physiological Sciences  (Lady Margaret Hall, Oxford)

1975     College Scholarship (Lady Margaret Hall)

Jo Poulton

Professor of Mitochondrial Genetics

Research Interests include:

  • Transmission and recurrence risks in mtDNA disease: The unique way in which mitochondrial DNA (mtDNA) is transmitted makes genetic counselling difficult. Dramatic changes in level of mutant mtDNA are attributable to a "genetic bottleneck" whereby a small number of mtDNAs become the founders for the offspring. We are studying the basis of this bottleneck in families and embryos, and are developing novel approaches to genetic counselling of mtDNA diseases, namely oocyte sampling and pre-implantation genetic diagnosis. 
  • Diseases of mtDNA maintenance: Control of mitochondrial copy number may be central to the pathogenesis of mtDNA disorders such as MtDNA depletion syndrome (MDS), Autosomal dominant Progressive External Ophthalmoplegia (AdPEO), Autosomal recessive Progressive External Ophthalmoplegia (ArPEO) and MyoNeuroGastroIntestinal Encephalomyopathy (MNGIE). These newly characterised mtDNA diseases are caused by mutations in autosomal genes, many of which are associated with a reduced quantity of defective mtDNA in affected tissues. We have therefore developed a method for quantitating the rate of mtDNA synthesis in cell lines derived from patients with these diseases. We are using this to study the 16189 variant, autosomally inherited defects in mtDNA maintenance and the basic science of mtDNA replication. We have also used this method to demonstrate consistent abnormalities in mtDNA synthesis in cell lines derived from such patients. Understanding the molecular mechanisms of these disorders may improve genetic counselling, and suggest novel therapies.
  • MtDNA variants in common multi-factorial diseases: We demonstrated that a common polymorphism, the mtDNA "16189 variant" is a risk factor for low birth weight to placental ratio, type2 diabetes and other multifactorial disorders. Because the 16189 variant has arisen many times independently, these associations are likely to be causal and not due to a founder effect. We are studying the molecular basis for these associations, which imply interactions of nuclear and mitochondrial genomes.


False False